Application value of preoperative enhanced multi-slice spiral CT scan in the surgical treatment for elderly patients with non-small cell lung cancer
-
摘要:
目的 探究术前多层螺旋CT增强扫描在老年非小细胞肺癌(NSCLC)患者手术治疗中的应用价值。 方法 回顾性分析2020年1月~2021年3月在本院接受治疗的120例老年NSCLC患者的临床资料,所有患者均接受多层螺旋CT增强扫描,分析多层螺旋CT诊断NSCLC的TNM分期、淋巴结转移与病理结果一致性,比较不同手术方式患者的手术情况和术后并发症发生情况。 结果 术前多层螺旋CT增强扫描诊断T分期、N分期、淋巴结转移和临床分期的准确率分别为89.17%、90.83%、87.10%、88.33%,与病理结果一致性较高(Kappa=0.789、0.792、0.787、0.776)。120例NSCLC患者中,98例接受手术治疗,其中57例患者接受肺楔形切除术+淋巴结清扫术,41例患者接受全肺叶切除术+淋巴结清扫术;接受肺楔形切除术患者的手术时间明显短于接受全肺叶切除术的患者,术中出血量和淋巴结清扫数量少于接受全肺叶切除术的患者,并发症发生率发生率明显低于接受全肺叶切除术的患者(P < 0.05)。 结论 多层螺旋CT增强扫描对老年NSCLC术前分期、淋巴结转移情况的诊断均具有较高准确度,可为手术方式的选择提供一定指导。 Abstract:Objective To explore the application value of preoperative enhanced multi-slice spiral CT scan in the surgical treatment for elderly patients with non-small cell lung cancer (NSCLC). Methods We retrospectively analyzed the clinical data of 120 elderly patients with NSCLC treated in the hospital between January 2020 and March 2021. All patients were subjected to enhanced multi- slice spiral CT scan. The consistency between multi- slice spiral CT and pathological results in diagnosing TNM stage and lymph node metastasis of NSCLC were analyzed. The operative conditions and postoperative complications of patients treated by different surgical methods were compared. Results The accuracy rates of preoperative enhanced multi-slice spiral CT scan in the diagnosis of T stage, N stage, lymph node metastasis and clinical stage were 89.17%, 90.83%, 87.10%, and 88.33%, which were consistent with pathological results (Kappa=0.789, 0.792, 0.787, 0.776). In the 120 patients with NSCLC, 98 received surgical treatment, including 57 patients undergoing pulmonary wedge resection and lymph node dissection, and 41 patients undergoing total lobectomy and lymph node dissection. The operation time of patients undergoing pulmonary wedge resection were significantly shorter than those of patients undergoing total lobectomy. The intraoperative blood loss and number of lymph nodes removed were less or smaller than those of patients undergoing total lobectomy, and the incidence of complications was significantly lower than that in patients undergoing total lobectomy (P < 0.05). Conclusion Enhanced multi- slice spiral CT scan has high accuracy in the diagnosis of preoperative stage and lymph node metastasis of NSCLC, thereby providing guidance for the selection of surgical methods. -
Key words:
- non-small cell lung cancer /
- elderly patient /
- multi-slice spiral CT /
- enhanced scan /
- surgical method
-
表 1 多层螺旋CT增强扫描诊断患者T分期与手术-病理T分期结果比较
Table 1. Comparison between T staging by enhanced multi-slice spiral CT scan and surgical-pathological T staging (n)
CT诊断 n 手术-病理T分期 准确率(%) T1 T2 T3 T4 T1 20 17 3 0 0 85.00 T2 73 0 69 4 0 94.52 T3 19 0 4 14 1 73.68 T4 8 0 0 1 7 87.50 合计 120 17 76 19 8 89.17 表 2 多层螺旋CT增强扫描诊断患者N分期与手术-病理N分期结果比较
Table 2. Comparison between N staging by enhanced multi-slice spiral CT scan and surgical-pathological N staging (n)
CT诊断 n 手术-病理T分期 准确率(%) N0 N1 N2 N0 55 50 5 0 90.91 N1 32 0 29 3 90.63 N2 33 1 2 30 90.91 合计 120 51 36 33 90.83 表 3 多层螺旋CT增强扫描诊断患者淋巴结转移与病理结果比较
Table 3. Comparison between the diagnostic results of enhanced multi-slice spiral CT scan and pathological results for lymph node metastasis (n)
CT诊断 手术-病理诊断 合计 有淋巴结转移 无淋巴结转移 有淋巴结转移 27 6 33 无淋巴结转移 4 83 87 合计 31 89 120 表 4 多层螺旋CT增强扫描诊断患者临床分期与病理结果比较
Table 4. Comparison between the diagnostic results of enhanced multi- slice spiral CT scan and pathological results for clinical stage (n)
CT诊断 n 手术-病理临床分期 准确率(%) ⅠA ⅠB ⅡA ⅡB ⅢA ⅢB ⅠA 34 30 3 1 0 0 0 88.24 ⅠB 29 2 26 1 0 0 0 89.66 ⅡA 21 1 1 19 0 0 0 90.48 ⅡB 14 0 0 1 12 1 0 85.71 ⅢA 12 0 0 0 2 10 0 83.33 ⅢB 10 0 0 0 0 1 9 90.00 合计 120 33 30 22 14 12 9 88.33 表 5 不同手术方式NSCLC患者手术指标及术后并发症发生情况比较
Table 5. Comparison of surgical indicators and postoperative complications in patients with NSCLC treated by different surgical methods (Mean±SD)
指标 肺楔形切除术(n=57) 全肺叶切除术(n=41) t/χ2 P 手术时间(min) 106.74±11.18 113.25±16.34 2.379 0.019 术中出血量(mL) 64.37±8.94 86.54±10.22 11.403 < 0.001 淋巴结清扫数量(个) 3.12±1.03 6.54±2.31 8.858 < 0.001 并发症发生率[n (%)] 6(10.53) 11(26.83) 4.421 0.036 -
[1] Tong YH, He Y, Hu LY, et al. Elevated proportion of collapsed microvessels indicate poor survival outcome in patients with nonsmall cell lung cancer[J]. Tumori, 2019, 105(6): 494-500. doi: 10.1177/0300891619871103 [2] Park S, Lee SM, Kim S, et al. Performance of radiomics models for survival prediction in non-small-cell lung cancer: influence of CT slice thickness[J]. Eur Radiol, 2021, 31(5): 2856-65. doi: 10.1007/s00330-020-07423-2 [3] 杨泽波. 胸腔镜肺癌手术对老年非小细胞肺癌患者心肺功能及血清免疫指标的影响[J]. 中国老年学杂志, 2018, 38(1): 137-9. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLXZ201801056.htm [4] Detillon DDEMA, Veen EJ. Postoperative outcome after pulmonary surgery for non-small cell lung cancer in elderly patients[J]. Ann Thorac Surg, 2018, 105(1): 287-93. doi: 10.1016/j.athoracsur.2017.07.032 [5] 杨振宇, 韦诗友, 夏粱, 等. 手术切除的N2期非小细胞肺癌预后影响因素探究[J]. 中国肺癌杂志, 2020, 23(1): 15-20. https://www.cnki.com.cn/Article/CJFDTOTAL-FAIZ202001004.htm [6] Rossi G, Bauckneht M, Genova C, et al. Comparison between 18FFDG PET-based and CT-based criteria in non-small cell lung cancer patients treated with nivolumab[J]. J Nucl Med, 2020, 61(7): 990-8. doi: 10.2967/jnumed.119.233056 [7] 王小刚, 杨茂生, 彭君, 等. 64排螺旋CT术前增强扫描在辅助诊断非小细胞肺癌淋巴结转移的应用价值分析[J]. 中国实验诊断学, 2018, 22(5): 777-80. doi: 10.3969/j.issn.1007-4287.2018.05.005 [8] Dietel M, Bubendorf L, Dingemans AM, et al. Diagnostic procedures for non-small-cell lung cancer (NSCLC): recommendations of the european expert group[J]. Thorax, 2016, 71(2): 177-84. doi: 10.1136/thoraxjnl-2014-206677 [9] Kale MS, Sigel K, Mhango G, et al. Assessing the extent of nonaggressive cancer in clinically detected stage Ⅰ non-small cell lung cancer[J]. Thorax, 2018, 73(5): 459-63. doi: 10.1136/thoraxjnl-2017-210309 [10] 李纪远, 张灿斌, 马新, 等. 胸腔镜肺叶切除术治疗非小细胞肺癌效果及生存分析[J]. 中国老年学杂志, 2019, 39(12): 2882-4. doi: 10.3969/j.issn.1005-9202.2019.12.017 [11] 李婵, 李涛. 老年非小细胞肺癌患者预后影响因素分析[J]. 中华肿瘤防治杂志, 2020, 27(22): 1844-9. https://www.cnki.com.cn/Article/CJFDTOTAL-QLZL202022013.htm [12] Moon Y, Sung SW, Park JK, et al. Prognostic factors of pathological N1 non-small cell lung cancer after curative resection without adjuvant chemotherapy[J]. World J Surg, 2019, 43(4): 1162-72. doi: 10.1007/s00268-018-04875-y [13] 姚青, 张兴, 刘昌, 等. 10年间3种病理学类型肝癌手术预后变化及其与肿瘤直径和淋巴结转移关系: 基于SEER数据库10672例病人长期预后分析[J]. 中国实用外科杂志, 2020, 40(11): 1308-13, 1319. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWK202011023.htm [14] 潘静, 朱晓强, 施健, 等. 64层螺旋CT仿真内镜联合CT靶扫描对中央型小细胞肺癌支气管表征改变的诊断价值[J]. 分子影像学杂志, 2021, 44(4): 678-81. doi: 10.12122/j.issn.1674-4500.2021.04.20 [15] Wu H, Dong S, Li X, et al. Clinical utility of dual-energy CT used as an add-on to 18F FDG PET/CT in the preoperative staging of resectable NSCLC with suspected single osteolytic metastases[J]. Lung Cancer, 2020, 140: 80-6. doi: 10.1016/j.lungcan.2019.10.032 [16] 马晓俊, 李显忠, 陆娟. 64排多层螺旋CT对直肠癌的初始治疗方法选择的指导意义[J]. 中国CT和MRI杂志, 2020, 18(10): 132-4. https://www.cnki.com.cn/Article/CJFDTOTAL-CTMR202010039.htm [17] 黄孝宇, 陈晓磊, 郭蕊馨. 多层螺旋CT评价非小细胞肺癌TNM分期与病理结果一致性的临床研究[J]. 中国CT和MRI杂志, 2018, 16 (7): 4-6, 54. https://www.cnki.com.cn/Article/CJFDTOTAL-CTMR201807002.htm [18] Cong M, Feng H, Ren JL, et al. Development of a predictive radiomics model for lymph node metastases in pre-surgical CTbased stage IA non-small cell lung cancer[J]. Lung Cancer, 2020, 139: 73-9. doi: 10.1016/j.lungcan.2019.11.003 [19] Abdel-Rahman O. Impact of timeliness of surgical treatment on the outcomes of patients with non-metastatic non-small cell lung cancer: findings from the PLCO trial[J]. World J Surg, 2019, 43(11): 2927-33. doi: 10.1007/s00268-019-05089-6 [20] 耿国军, 于修义, 米彦军, 等. 食管、肺双原发癌胸腔镜下同期手术17例报告[J]. 中国微创外科杂志, 2018, 18(3): 213-6. https://www.cnki.com.cn/Article/CJFDTOTAL-ZWWK201803006.htm [21] Zhang H, Liu C, Tan Z, et al. Segmentectomy versus wedge resection for stage Ⅰ non-small cell lung cancer: a meta- analysis[J]. J Surg Res, 2019, 243: 371-9. [22] 汤隽, 赵俊刚, 郑福爽, 等. 老年外周型早期非小细胞肺癌行单孔胸腔镜下肺段切除术的疗效及安全性[J]. 中国老年学杂志, 2018, 38 (13): 3130-1. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLXZ201813024.htm [23] Mimae T, Saji H, Nakamura H, et al. Survival of octogenarians with early-stage non-small cell lung cancer is comparable between wedge resection and lobectomy/segmentectomy: JACS1303[J]. Ann Surg Oncol, 2021: 1-9. doi: 10.1245/s10434-021-09835-w [24] 张新峰. 胸腔镜肺段与肺叶切除术治疗早期非小细胞肺癌效果及对患者临床指标、肺功能影响观察[J]. 中国全科医学, 2018, 21(S2): 153-5. https://www.cnki.com.cn/Article/CJFDTOTAL-QKYX2018S2057.htm [25] Schmid S, Csanadi A, Kozhuharov N, et al. CC-chemokine ligand 18 is an independent prognostic marker in lymph node-positive nonsmall cell lung cancer[J]. Anticancer Res, 2018, 38(7): 3913-8. http://www.onacademic.com/detail/journal_1000040530636110_048e.html